Inventor · disambiguated record
Bengt Ingemar Samuelsson
Also filed as: SAMUELSSON BENGT · SAMUELSSON BENGT INGEMAR · VOORHEES JOHN J
14 granted patents·13 pending applications·162 citations·filing 1977–2024
90Inventor score
Files withENLITISA SHANGHAI PHARMACEUTICAL CO LTD12JIANGYIN BENGT I SAMUELSSON INST OF LIFE SCIENCE CO LTD4KAROLINSKA INNOVATIONS AB4JIANGYIN USUN PHARMACEUTICAL CO LTD3MICHIGAN UNIVERSITY OF REGENTS2
Top patents by PatentIndex Score
27 records- 0192US4181725AMethod for alleviating psoriasisMICHIGAN UNIVERSITY OF REGENTS·Filed 1977·Granted Jan 1, 1980·120 cites·12 claims
- 0287US10568938B2Mussel adhesive protein product and applications thereof in suppression of skin inflammationsJIANGYIN BENGT I SAMUELSSON INST OF LIFE SCIENCE CO LTD·Filed 2015·Granted Feb 25, 2020·4 cites·8 claims
- 0385US10485848B2Mussel adhesive protein product and use thereof for treating mucosal inflammationJIANGYIN BENGT I SAMUELSSON INST OF LIFE SCIENCE CO LTD·Filed 2016·Granted Nov 26, 2019·5 cites·11 claims
- 0481US11260111B2Mussel adhesive protein product and applications thereof in suppression of skin inflammationsJIANGYIN BENGT I SAMUELSSON INST OF LIFE SCIENCE CO LTD·Filed 2020·Granted Mar 1, 2022·1 cites·10 claims
- 0578US2025302818A1Topical formulations comprising montelukast and combinations with mussel adhesive proteinsENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0673US11672792B2Topical formulations comprising montelukast and combinations with mussel adhesive proteinsENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2018·Granted Jun 13, 2023·1 cites·19 claims
- 0773US2023404992A1Topical formulations comprising montelukast and combinations with mussel adhesive proteinsENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 0872US2025041377A1Pharmaceutical useENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0970US11458190B2Mussel adhesive protein product and use thereof for treating mucosal inflammationJIANGYIN BENGT I SAMUELSSON INST OF LIFE SCIENCE CO LTD·Filed 2019·Granted Oct 4, 2022·0 cites·6 claims
- 1069US2024218016A1Peptides and their use in the treatment of inflammationSHENZHEN INST ADV TECH·Filed 2020·Application pending·0 cites
- 1169US2023348536A1Conjugates of montelukast and peptidesENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1267US2023113836A1New conjugates of peptides and polysaccharideENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 1366US12129313B2Anti-inflammatory use of peptideENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Oct 29, 2024·0 cites·14 claims
- 1466US7192733B2Methods and means for modulating PGE synthase activityKAROLINSKA INNOVATIONS AB·Filed 2004·Granted Mar 20, 2007·3 cites·2 claims
- 1564US11680082B2Conjugates of montelukast and peptidesENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Jun 20, 2023·0 cites·40 claims
- 1663US4190669AMethod for treating psoriasisMICHIGAN UNIVERSITY OF REGENTS·Filed 1977·Granted Feb 26, 1980·17 cites·11 claims
- 1761US7067296B2Methods and means for modulating PGE synthase activityKAROLINSKA INNOVATIONS AB·Filed 2002·Granted Jun 27, 2006·1 cites·5 claims
- 1858US7645601B2Methods and means for modulating PGE synthase activityKAROLINSKA INNOVATIONS AB·Filed 2007·Granted Jan 12, 2010·0 cites·19 claims
- 1956US2024316029A1New treatment of immunodeficiency disorderENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2055US2025066417A9New peptide-based diagnostic and therapeutic agentsENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 2154US6395502B1Method and means for modulating PGE synthase activityKAROLINSKA INNOVATIONS AB·Filed 1999·Granted May 28, 2002·10 cites·22 claims
- 2254US2021196783A1New pharmaceutical useJIANGYIN USUN PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 2351US2023331792A1New multi-functional oligopeptidesENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2450US2024124521A1New peptidesENLITISA SHANGHAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2549US11059859B2Anti-inflammatory use of peptideJIANGYIN USUN PHARMACEUTICAL CO LTD·Filed 2018·Granted Jul 13, 2021·0 cites·8 claims
- 2649US2022105082A1New formulations containing leukotriene receptor antagonistsJIANGYIN MUCOCARE PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2747US2024165247A1New peptide conjugatesJIANGYIN USUN PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →